|
WRNIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.40969999509844E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52190002214547E-09 |
| Normal-vs-Stage2 |
4.43390000048893E-07 |
| Normal-vs-Stage3 |
5.428000E-04 |
| Normal-vs-Stage4 |
4.741200E-03 |
| Stage1-vs-Stage2 |
5.571800E-01 |
| Stage1-vs-Stage3 |
4.266800E-01 |
| Stage1-vs-Stage4 |
5.748600E-01 |
| Stage2-vs-Stage3 |
2.585200E-01 |
| Stage2-vs-Stage4 |
3.376400E-01 |
| Stage3-vs-Stage4 |
9.690600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73490000143772E-09 |
| Normal-vs-AfricanAmerican |
1.86369999999325E-06 |
| Normal-vs-Asian |
2.189700E-02 |
| Caucasian-vs-AfricanAmerican |
4.464400E-01 |
| Caucasian-vs-Asian |
5.217200E-01 |
| AfricanAmerican-vs-Asian |
7.081800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50800047396638E-10 |
| Normal-vs-Female |
1.449900E-04 |
| Male-vs-Female |
1.732010E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.46440000000381E-05 |
| Normal-vs-Extreme_Weight |
7.01950053638711E-10 |
| Normal-vs-Obese |
8.86389999954496E-07 |
| Normal-vs-Extreme_Obese |
5.403500E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.758600E-01 |
| Normal_Weight-vs-Obese |
9.380600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.431000E-01 |
| Extreme_Weight-vs-Obese |
2.510000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.675200E-01 |
| Obese-vs-Extreme_Obese |
8.655800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.269600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.41339999984547E-07 |
| Normal-vs-Age(61-80Yrs) |
2.14320006186597E-10 |
| Normal-vs-Age(81-100Yrs) |
4.35699999967731E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.543420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.142100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.284500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.992300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.278000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.9693000048201E-08 |
| Normal-VS-Type2 PRCC |
1.54590007461763E-10 |
| Normal-VS-KIRP CIMP |
3.624200E-01 |
| Normal-VS-Unclassified PRCC |
4.36740000053781E-07 |
| Type1 PRCC-VS-Type2 PRCC |
3.057500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.144580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.553800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.622300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.798600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.005800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.53019868682259E-11 |
| Normal-vs-N1 |
2.109600E-02 |
| Normal-vs-N2 |
3.69940000000124E-05 |
| N0-vs-N1 |
6.779000E-04 |
| N0-vs-N2 |
1.578950E-01 |
| N1-vs-N2 |
1.288210E-02 |
|
|
